Trial Profile
Effect of food on the pharmacokinetics of ticagrelor
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Aug 2012
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes; Embolism and thrombosis
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 01 Aug 2012 Results published in the Journal of Clinical Pharmacy and Therapeutics.
- 05 Nov 2010 New trial record.